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ABSTRACT
Objective: The objective of the present investigation was to improve the solubility and dissolution rate of poorly soluble drug meloxicam by its 
ternary inclusion complexation with natural polymers and beta-cyclodextrin (β-CD) by kneading.
Methods: Equimolar physical mixture (1:1) was prepared by homogeneously kneading drug and β-CD using a solution of agar and pectin in water 
to get a paste, then paste was dried overnight to get inclusion complex. Inclusion complex was evaluated for drug content, the yield of the adsorption 
process, Fourier-transform infrared (FTIR), differential scanning calorimeter (DSC), powder X-ray diffractometry (PXRD), scanning electron 
microscopy (SEM), dissolution, and stability studies.
Results: The phase solubility diagrams exhibit AL showing a linear increase of drug solubility and indicating the formation of soluble complexes. The 
FTIR and DSC show compatibility between meloxicam and β-CD, while slight broadening in the peak with a reduction in intensity and early onset 
indicates the reduction in drug crystallinity which confirms in PXRD pattern. The SEM of binary, as well as ternary, showed no aggregation, and there 
was a gap between the particles also indicating good redispersibility. The dissolution rate of the drug from the kneaded ternary complex with pectin 
was significantly rapid compared with the pure drug. The maximum drug release was observed at 85.21±1.84% at the end of 60 min. The ternary 
complex was found stable after 3 months stability studies.
Conclusion: The results indicated that ternary inclusion complexation with natural polymers and β-CD was most useful for enhancement of solubility 
and dissolution rate of a poorly soluble drug like meloxicam.
Keywords: Meloxicam, β-cyclodextrin, Natural polymers, Ternary complex, Solubility enhancement.
INTRODUCTION
Cyclodextrin inclusion complexes play an important role in improving 
the therapeutic efficacy of drugs with poor solubility and/or stability 
problems. They are capable of alleviating the undesirable properties of 
drug molecules through the formation of inclusion complexes [1]. Beta-
cyclodextrin (β-CD) is a basic cyclodextrin and hence selected for its higher 
solubility, and this generally results in more extensive solubilization 
ability toward lipophilic molecules, with a good safety profile [2]. 
However, cyclodextrin has problems such as high molecular mass, 
rather a high cost and potential parenteral toxicity [3]. Strengthening the 
complexation and solubilization efficacy of cyclodextrins is possible by 
the use of the ternary agent which may act as a binding agent between 
cyclodextrin and guest molecule and/or act by solubilizer. Apart from 
several approaches toward this aim is the addition of suitable auxiliary 
substances, which can be a useful approach to increase cyclodextrin 
solubilizing capacity by ternary complex [4-6]. CDs can accommodate a 
variety of molecules inside the cavity due to its shape to form inclusion 
compounds. The guest molecules encapsulated by CDs may undergo 
some changes in their physical, chemical, or biological properties. This 
feature has been advantageously exploited for increasing the stability 
and bioavailability of drugs [7-9]. Instead of attempting only binary 
inclusion complex addition of small amounts of water-soluble polymers 
to the system, which causes an increase in solubilization efficiency and 
may result in reducing amounts of CD [10,11]. These results can be 
attributed to the synergistic effect of polymer and CD solubilization on the 
formation of drug: CD:water-soluble polymer ternary complexes [12,13]. 
Water-soluble polymers are able to interact with drugs, CD molecules, 
and even with the drug: CD complexes [3]. The mechanism involved in 
increasing CD complexation efficiency in the presence of water-soluble 
polymers is not yet fully understood; however, it is believed that water-
soluble polymers can reduce CD mobility and increase the complex 
solubility [14]. Cyclodextrin ternary complexes have been tried for 
overall enhancement of solubility and dissolution rate with carboxylic 
acid [15,16], amino acids [17,18], sugar alcohol [19], and hydrophilic 
polymer [20,21]. There are different types of the hydrophilic polymer 
have been tried including synthetic and semi-synthetic, but there was a 
rare use of natural polymer for this purpose [22].
Meloxicam (4-hydroxy-2-methyl-N-{5-methyl-2-thiazolyl}-H-1, 2 
benzothiazine-3-carboxamide 1, 1-dioxide) is a potent nonsteroidal 
anti-inflammatory drug. It is practically insoluble in water (12 mg/mL1). 
Its poor solubility and wettability lead to difficulties in oral and 
parenteral formulations. In the present investigation, attempt was 
made to improve solubility and dissolution rate of the poorly soluble 
drug using ternary complexation with β-CD and natural polymers such 
as agar and pectin as natural polymers have several advantages over 
synthetic or semi-synthetic polymers.
MATERIALS AND METHODS
Material
Meloxicam was obtained as a gift sample from Cipla Ltd., Mumbai, India. 
β-CD was gifted by Lupin Ltd Pune. All other chemicals and solvents used 
were of pharmaceutical and analytical grade. Double distilled water was 
used throughout the study for all the experimental procedures.
Phase solubility studies
The solubility behavior of meloxicam was examined in distilled water at 
room temperature (25±2°C) according to the method described by Higuchi 
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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and Connors 1965 [23]. Known excess amounts of ME (50 mg) were added 
to 20 mL of aqueous solutions of various concentrations of β-CD ranging 
between 1 mM and 15 mM. The suspensions were vigorously shaken in a 
shaking water bath at 25±0.5°C for 2 days. After equilibrium was attained, 
saturated solutions were centrifuged, and the supernatants were filtered 
through a 50–mm Millipore filter. After suitable dilution, samples were 
assayed for ME concentration using a uitraviolet (UV) spectrophotometer 
(Shimadzu UV spectrophotometer 1800) at λmax of 360 nm against blank 
prepared in the same concentration of β-CD. To establish the effect of 
natural polymers (pectin and agar) on the solubility diagram, each was 
added separately at a concentration of 0.5% (m/V) to a suspension of 
ME-β CD and then allowed to equilibrate at 25±0.5°C for 2 days. The each 
solubility was investigated using the previously described method and 
performed in triplicate. The phase solubility diagram was constructed 
by plotting the dissolved Meloxicam concentration against the respective 
concentration of β-CD. The binding constant Ka was calculated from a 
phase solubility diagram using its slope and intercept values [24]. Phase 
solubility study graph is given in Fig. 1.
PREPARATION OF SOLID COMPLEXES
Preparation of binary complex by kneading
In this method, the equimolar physical mixture of 1:1 was prepared 
by homogeneously blending exactly weighed amounts of drug and 
β-CD until the homogenous mixture is obtained and 1.5 times of water 
to the total weight of the physical mixture was added slowly during 
continuous kneading. The mixture is kneaded for about 1 h to get the 
paste. Then, this paste was allowed to dry at room temperature for 24 h 
in dark place to protect it from light, and then the dried powder sieved 
to get uniform particle size distribution [25].
PREPARATION OF TERNARY COMPLEX BY KNEADING
Ternary inclusion complexes were prepared by slight modification 
in the above mention method to add a ternary agent that is a natural 
hydrophilic polymer. An equimolar physical mixture of 1:1 was prepared 
by homogeneously blending exactly weighed amounts of drug and β-CD 
until the homogenous mixture is obtained and sufficient volume of 0.5% 
aqueous solution of natural polymer Pectin and Agar was added slowly 
during continuous kneading to get ternary complexes. The mixture is 
kneaded for about 1 h to get the paste. Then, this paste was allowed to 
dry at room temperature for 24 h in dark place to protect it from light, and 
then the dried powder sieved to get uniform particle size distribution [25].
Characterization of solid complexes
Drug content and yield of kneading process
Kneaded solid complex (10 mg) was weighed accurately and extracted 
using 100 mL of phosphate buffer pH 6.8 by shaking for 12 h on a 
rotary shaker. After shaking the sample filter through Whatman 
filter paper and after sufficient dilutions, samples were analyzed 
spectrophotometrically at 238 nm (Shimadzu UV spectrophotometer 
1800). Drug content was calculated from the standard curve of 
meloxicam in phosphate buffer pH 6.8 [26] yield of the kneading 
process was determined by the corelating weight of added solute to 
that of recovered one.
Fourier transform-infrared (FT-IR) spectrophotometer studies
FT-IR has been employed as a useful tool to identify drug excipient 
interaction. Samples were analyzed by the potassium bromide pellet 
method in an IR spectrophotometer (Alpha T Bruker) in the region from 
4000 to 400 cm−1. Pure meloxicam, binary solid complexes and ternary 
solid complexes with agar and pectin were evaluated by comparing its 
FT-IR spectra. FT-IR spectra of Pure nifedipine and adsorbed product 
are shown in Fig. 2.
Differential scanning calorimeter (DSC) analysis
DSC has been one of the most widely used calorimetric techniques to 
study the solid state interaction of the drug with other ingredients [27]. 
Samples of the pure drug and adsorbed product were taken in flat-
Fig. 1: Phase solubility diagram of meloxicam beta-cyclodextrin (β-CD) binary system, meloxicam β-CD –Agar ternary system, and 
meloxicam β-CD- Pectin ternary system
Fig. 2: Fourier transform infrared spectra of (a) pure meloxicam, 
(b) pure β-cyclodextrin and (c) meloxicam beta-cyclodextrin 
(β-CD) binary complex (d) pure agar (e) meloxicam β-CD-agar 
ternary complex (f) Pure pectin (g) meloxicam β-CD-pectin 
ternary complex
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bottomed aluminum pans and heated over a temperature range of 30–
300 °C at a constant rate of 10/min with purging of nitrogen (50 ml/min) 
using alumina as a reference standard in a DSC (Mettler Toledo, Staresw 
920). The DSC thermogram of pure meloxicam and kneaded solid 
complexes is shown in Fig. 3.
Powder X-ray diffractometry (PXRD) analysis
The powder X-ray diffraction technique has been extensively utilized 
to study the interac tion and to obtain the changes in the crystallinity 
of the kneaded product. PXRD study was carried out using X-ray 
diffractometer (Miniflex 600 X-ray diffractometer, Rigaku corporation 
Japan). For this the samples of pure drug and kneaded product were 
irradiated with monochromatized CuKα radiation and analyzed from 
5 to 60 (2θ) [28]. The PXRD diffractograms of pure meloxicam and 
kneaded solid complexes are shown in Fig. 4.
Scanning electron microscopy (SEM) studies
The surface morphology of pure meloxicam and kneaded solid 
complexes was observed using a SEM (VEG A3 TESCAN), under 
accelerating voltage of 15 keV. Samples were fixed on SEM stub with 
double-sided adhesive tape and then coated in a vacuum with a thin 
gold layer before investigation [29]. The SEM images of pure meloxicam 
and kneaded solid complexes are shown in Fig. 5.
DISSOLUTION STUDIES IN PHOSPHATE BUFFER
An accurately weighed amount of pure meloxicam, binary solid complex, 
and ternary solid complexes with agar and pectin equivalent to 15 mg of 
added to the dissolution medium. The dissolution study was performed 
in phosphate buffer pH 7.4. The dissolution study was carried out using 
USP apparatus II (EDT 08LX Electrolab) at 37±0.5°C and 100 rpm 
paddle speed. The samples were withdrawn from dissolution media at 
specified time interval up to 120 min, and the absorbance of the sample 
was recorded using UV (Shimadzu UV spectrophotometer 1800) at λmax 
of 360 nm against blank [30]. Dissolution profiles are shown in Fig. 6.
Stability study
Stability study for meloxicam ternary complex with pectin by kneading 
was carried out with the help of stability chamber (Remi SC-19 Plus) by 
storing 1 gm of the above sample in an ambered colored screw-capped 
glass bottles at accelerated and controlled temperatures 40°C and 
relative humidities (75%) for 3 months [31-33]. The physical mixture 
was evaluated for physical appearance and in vitro dissolution at the 
end of 3 months.
RESULTS AND DISCUSSION
Phase solubility studies
Phase solubility diagrams of ME in the binary system with β-CD, a 
ternary system with β-CD agar and β-CD pectin in aqueous solutions at 
25°C is illustrated in Fig. 1. Solubility diagrams exhibit AL type according 
to the Higuchi and Connors classification [23], showing a linear increase 
of drug solubility on increasing β-CD concentration and indicating the 
formation of soluble complexes. The slopes of the curve were found to be 
0.00644, 0.0119, and 0.0129 in case of binary complex, ternary complex 
with agar, and ternary complex with pectin, respectively. A slope value 
of <1.00 indicates the formation of an inclusion complex in a molar 
stoichiometric ratio of 1: 1 between the meloxicam and β-CD in a solution 
of the hydrophilic natural polymeric solution. The ratio between the 
slopes of the phase solubility curves of ternary and binary systems, as 
an index of the relative solubilizing efficiency, was 1.87 for agar and 2.02 
for pectin, confirming the greater effectiveness of the ternary system. 
The stability constant (Ks) computed from the slope and intercept of the 
phase solubility diagram was found to be 587.24 M−1, 912.23 M−1, and 
1021.58 M−1 in case of the binary system, ternary system with agar, and 
ternary system with pectin indicating an increase in stability constant 
value of ternary system compared to the binary system. The mechanism 
involved in enhancing the solubility of meloxicam may be due to the 
synergistic effect of solubilization effect of natural hydrophilic polymer 
and inclusion complexation of ME with β-CD.
Fig. 4: Powder X-ray diffractometry diffractograms for (a) pure 
meloxicam, (b) binary complex (c) ternary complex with agar  
(d) ternary complex with pectin
Fig. 5: SEM images of (a) pure meloxicam (b) pure beta-




Fig. 3: DSC thermograms of (a) pure meloxicam, (b) pure beta-
cyclodextrin (β-CD), and (c) meloxicam-β-CD -pectin ternary 
complex
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Drug content and yield of kneading process
The drug content of binary solid complex and ternary solid complexes 
was determined using a previously reported method [26]. The practical 
drug content of binary solid complex, ternary complex with agar, and 
ternary complex with pectin was found to be 22.10±0.23, 21.85±0.47, 
and 21.90±0.42, respectively, which corresponded to the ratio of the drug 
with β-CD and a natural hydrophilic polymer. The yield of the kneading 
process was found more than 98% which indicates negligible loss during 
kneading and its recovery after overnight drying. The greater yield of 
the kneading process as compared to another method of complexation 
like spray drying makes a suitable method for preparation of binary 
and ternary complexation. There was no any significant difference in 
complexation efficiency between kneading method and spray drying 
method reported by the previous researcher [15] confirms kneading 
method is a suitable method for formation of inclusion complex as it 
is time saving and simple. The theoretical drug content, practical drug 
content, and yield of the kneading process are summarized in Table 1.
FT-IR spectrophotometer studies
The FT-IT analysis has been carried out to study the interaction between 
meloxicam with β-CD and natural hydrophilic polymers and to study 
complexation by kneading. The pure meloxicam showed characteristic 
at 1620 cm−1 (C=O Stretching for Amide), 3292 cm−1 (N-H Stretching for 
Amide, 2923 cm−1 (Ar- CH Stretching), 1185 cm−1 and 1346 cm−1 for S=O 
Stretching vibration of sulfonamide group, 1267 cm−1 for C-N Stretching 
vibration of Aliphatic amine, etc., confirming the earlier reported peaks. 
The FTIR spectra of β-CD were characterized by an intense band 
between 3700 cm−1 and 3000 cm−1 (OH Stretching), a peak at 2917.77 
cm−1 (Aliphatic CH Stretching), a broad peak at 1635.34 cm-1, and a 
band with distinct peaks in the region between 1200 and 1000 cm−1. 
Typical principle peaks not showed any shift in IR spectra in binary or 
ternary solid complex, confirmed that there is no interaction between 
β-CD, natural hydrophilic polymer, and guest molecule. The bending 
vibrations of the aromatic ring were not observed in the spectra of the 
kneaded product either in binary or ternary solid complex, indicating 
that the vibrating and bending of the guest molecule were restricted due 
to formation of inclusion complex, this dramatic change was probably 
related to the formation of intermolecular hydrogen bonds between the 
guest and host molecules [34]. The FTIR spectra of meloxicam–β-CD 
kneading binary solid complex and its ternary complexes with agar and 
pectin not showed any new peak, indicating no chemical bond were 
created in the formed compound. The FI-IR spectra of pure meloxicam, 
binary solid inclusion complex, and ternary solid inclusion complex 
with the natural hydrophilic polymer are shown in Fig. 2.
DSC analysis
DSC analyses were performed to evaluate the thermal behavior of 
meloxicam, in the presence of β-CD and natural polymers used in 
binary and ternary solid inclusion complexes. When guest molecule 
incorporated into cyclodextrin central cavity, their melting point shifts 
to the different temperature, or it may disappear. One sharp endothermic 
peak was observed near around 254°C with onset at 248°C contributed 
to the melting point of crystalline meloxicam in the thermogram of pure 
drug. Meloxicam-β-CD-pectin ternary complex showed onset 247°C 
and peak at 252°C with slight broadening in peak as well reduction 
in intensity and early onset as compared to the pure drug indicates a 
reduction in drug crystallinity and conversion in the amorphous form 
which is the positive effect for solubility enhancement. The shift in the 
dehydration band of β-CD in the spectra of the kneaded product can be 
attributed to the formation of inclusion complex of the drug with β-CD. 
The reduction in the enthalpy of fusion of the drug has been reported 
to be an indication for the formation of an inclusion complex with β-CD. 
The DSC thermograms of pure meloxicam, pure β-CD, and ternary solid 
complex are shown in Fig. 3.
PXRD analysis
The powder X-ray diffraction spectroscopy was used to asses the 
degree of crystallinity of the given sample due to complexation of the 
poorly soluble drug by kneading. When the drug goes to the cavity of 
β-CD and forms soluble inclusion complex, overall crystallinity of drug 
decreases and with an increases in amorphous nature. Pure meloxicam 
showed numerous distinctive peaks at 14.96, 25.86, 25.90, etc., with 
high peak intensity that indicated a high crystallinity; however, peak 
intensity decreased in the binary complex of drug with β-CD indicating 
conversion of the drug in amorphous form. The peak intensity further 
decreased in a ternary complex with agar as compared to the binary 
complex and observed very less in case of the ternary complex with 
pectin indicates the addition of ternary agent is beneficial to decrease 
crystallinity of a drug. The conversion of crystalline nature of drug to 
amorphous nature of help in increasing its solubility in different pH 
Fig. 6: Dissolution studies of pure meloxicam, binary complex, ternary complex with agar, and ternary complex with pectin
Table 1: Drug content and yield of kneading process for the binary and ternary complex




*Yield of kneading 
process (%)
Binary complex 23.64 22.10±0.23 98.05±0.44
Ternary with agar 23.41 21.85±0.47 98.50±0.34
Ternary with pectin 23.41 21.90±0.42 98.10±0.53
*Represents mean±Standard deviation (n=3)
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conditions of GI tract. Significant reduction in peak intensities in PXRD 
pattern was observed in case ternary complex in the presence of natural 
hydrophilic polymer, as compared to the pure drug was attributed to 
the synergistic effect of β-CD and agar or pectin. PXRD diffractograms 
of pure meloxicam, binary complex, and ternary complex with agarand 
ternary complex with pectin are shown in Fig. 4.
SEM studies
The SEM study was done to check surface morphology of the meloxicam 
particles and its relevant changes when complexed as a binary and 
ternary inclusion complex using the kneading method. Pure meloxicam 
image shows crystalline rectangular shape particles, whereas an image 
of the solid binary complex of the drug does not show any crystalline 
material indicating kneading of meloxicam with β-Cd in binary complex 
helps to convert crystalline form of the drug to amorphous form. The 
similar types of results observed in SEM images of ternary kneading 
complex that is drug converted to the amorphous form which was 
a positive effect for the enhancement of solubility. Pure meloxicam 
shows crystalline rectangular shape while β-CD was observed to be 
irregular in shape, but this original morphology of both components 
had disappeared in binary and ternary solid inclusion complex. These 
changes suggested the formation of inclusion complex; moreover, SEM 
of binary as well as ternary showed no aggregation, and there was a gap 
between the particles also, indicating good redispersibility. The SEM 
images of pure meloxicam, pure β-Cd, binary inclusion complex, and 
ternary inclusion complex with pectin are shown in Fig. 5.
In vitro dissolution studies in phosphate buffer
The dissolution study was carried out in phosphate buffer pH 7.4 for 
comparison of percent drug release of pure meloxicam with binary 
and different ternary inclusion complex. Pure meloxicam showed drug 
dissolution of 18.87±0.90% in 30 min while meloxicam-β-Cd binary 
complex showed the dissolution of 41.56±1.52% in 30 min. The percent 
drug release dissolution further increased in the ternary complex with 
agar as well as pectin and which was found to be 53.64±1.88 and 
60.21±1.54, respectively. The maximum drug release was found to be 
85.21±1.84% at the end of 60 min from meloxicam ternary complex 
with pectin which was highest drug release compared to ternary 
complex with agar as well as binary complex indicating ternary 
complex with natural hydrophilic polymer pectin showed better drug 
dissolution in phosphate buffer 6.8. Increase in the dissolution rate 
was recorded for solid complexes compared to the pure drug. It can be 
assumed that, in the dissolution process, β-Cd molecules will operate 
locally surrounding the drug particles. This action resulted in the rapid 
increase in the amount of dissolved drug. The order of drug dissolution 
was found to be ternary complex with pectin > ternary complex with 
agar > binary complex > pure meloxicam indicating that the ternary 
complex with pectin is more promising for the enhancement of 
solubility as well as drug dissolution of meloxicam. The increase in drug 
dissolution is the result of the synergistic action of β-CD and the natural 
hydrophilic polymer. The dissolution profiles of pure meloxicam, binary 
complex, ternary complex with agar, and pectin in phosphate buffer 7.4 
are shown in Fig. 6.
Stability studies
There was no significant change in the physical appearance and percent 
drug dissolution in the kneaded product of meloxicam. A stability results 
indicate that kneaded product was sufficiently stable under accelerated 
and controlled conditions. No change in physical appearance and other 
parameters indicates that solid complex product was found stable 
under accelerated temperature condition as it gives more protection to 
the drug as compared to drug alone as drug enclosed in the cavity of 
β-CD.
CONCLUSION
The present study determined the utility ternary complexation with the 
natural hydrophilic polymer to enhance the solubility and dissolution 
rate of the BCS Class-II drug meloxicam. Dissolution study indicates 
that ternary complex with pectin is most useful for enhancement of 
solubility of meloxicam as compare to the drug alone. Meloxicam-β Cd-
pectin ternary kneaded product can be used for further development of 
an oral solid drug delivery system to overcome the solubility problem.
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